Fumiki Asanuma
- Co-authors
- Tetsuro KubotaKyuya IshibikiYoshinori YamadaYasunori HoshiyaY. YamadaTsukasa InadaMasaki KitajimaRichard M. Hoffman
- Topics
- Cancer Treatment and Pharmacology (10 papers)Colorectal Cancer Treatments and Studies (9 papers)Cancer therapeutics and mechanisms (7 papers)
- Cited by
- BiotechnologyOncologyCancer Research
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Fumiki Asanuma
47 papers receiving 324 citations
Peers
Comparison fields: 5 of 59
- Oncology 145
- Molecular Biology 120
- Pulmonary and Respiratory Medicine 70
- Cancer Research 61
- Surgery 52
Countries citing papers authored by Fumiki Asanuma
This map shows the geographic impact of Fumiki Asanuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiki Asanuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiki Asanuma more than expected).
Fields of papers citing papers by Fumiki Asanuma
This network shows the impact of papers produced by Fumiki Asanuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiki Asanuma. The network helps show where Fumiki Asanuma may publish in the future.
Co-authorship network of co-authors of Fumiki Asanuma
This figure shows the co-authorship network connecting the top 25 collaborators of Fumiki Asanuma. A scholar is included among the top collaborators of Fumiki Asanuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiki Asanuma. Fumiki Asanuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 25 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 17 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 25 | |
| 13 | Human tumors are methionine dependent in vivo. | 60 |
| 14 | 3 | |
| 15 | 9 | |
| 16 | Succinic dehydrogenase inhibition chemosensitivity test for solid tumors and its clinical predictability | 2 |
| 17 | 2 | |
| 18 | Cell kinetics and chemosensitivity of human carcinomas serially transplanted into nude mice. | 33 |
| 19 | [Experimental chemo- and endocrine-therapy of a human breast carcinoma cell line (MCF-7) in vitro and in vivo]. | 1 |
| 20 | 1 |
About Fumiki Asanuma
Fumiki Asanuma is a scholar working on Toxicology, Oncology and Biotechnology, having authored 51 papers that have together received 336 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (9 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Biotechnology (52 citations), Oncology (145 citations) and Cancer Research (61 citations). Fumiki Asanuma has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Tetsuro Kubota, Kyuya Ishibiki, Yoshinori Yamada, Yasunori Hoshiya, Y. Yamada, Tsukasa Inada, Masaki Kitajima, Richard M. Hoffman, Koichiro Yoshino and Osahiko Abe. Their work appears in journals such as European Journal of Cancer, World Journal of Surgery and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.